Impact of age on treatment strategies in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study
ANNÉE
2022
AUTEURS
Carola E, Chibaudel B, Boulahssass R, Dourthe LM, André T, Henriques J, Bourgeois V, Etienne P, Desrame J, Dupuis O, Baba-Hamed N, Auby D, Louvet C, Maillard E, Tournigand C, Garcia-Larnicol ML, Shacham Shmueli E, Bird BH, Ghiringhelli F, De Gramont A
CONGRÈS/REVUE
ESMO
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES